Dr. Maximos is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
651 N Egret Bay Blvd Fm270
Suite H
League City, TX 77573Phone+1 832-632-1333Fax+1 832-632-1777
Education & Training
- Rutgers Health/Robert Wood Johnson Medical SchoolResidency, Obstetrics and Gynecology, 2005 - 2007
- Louisiana State University School of MedicineResidency, Obstetrics and Gynecology, 2003 - 2005
- St. George's University School of MedicineClass of 2003
Certifications & Licensure
- CA State Medical License 2007 - Present
- TX State Medical License 2007 - 2025
- NJ State Medical License 2005 - 2009
- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Publications & Presentations
PubMed
- 16 citationsA novel vaginal pH regulator: results from the phase 3 AMPOWER contraception clinical trial.Michael A. Thomas, B. Todd Chappell, Bassem Maximos, Kelly R. Culwell, Clint Dart
Contraception. 2020-07-01 - 54 citationsZuranolone for the Treatment of Postpartum Depression.Kristina M Deligiannidis, Samantha Meltzer-Brody, Bassem Maximos, E Quinn Peeper, Marlene Freeman
The American Journal of Psychiatry. 2023-09-01 - 21 citationsPhase 3 study evaluating the safety and efficacy of oteseconazole in the treatment of recurrent vulvovaginal candidiasis and acute vulvovaginal candidiasis infections.Mark G Martens, Bassem Maximos, Thorsten Degenhardt, Karen Person, Stacey Curelop
American Journal of Obstetrics and Gynecology. 2022-12-01
Press Mentions
- Out of the Dark: A Journey Through Postpartum Depression, Part 2June 18th, 2021
- Marinus Pharmaceuticals Announces Data from Magnolia and Amaryllis Phase 2 Studies in Women with Postpartum DepressionJuly 23rd, 2019
- Evofem Biosciences Shows Positive Top-Line Phase 3 Results for Hormone-Free Birth ControlDecember 17th, 2018
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: